Showing results (61-70 of 138) with videos related to

Sort By:
Pageof 14
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2003
The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugsGlen Reid, Peter Wielinga, Noam Zelcer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 29, 2011
Transportomics: screening for substrates of ABC transporters in body fluids using vesicular transport assaysPetra Krumpochova, Sunny Sapthu, Jos F Brouwers, et al.
Nature|May 9, 2008
Domain organization of human chromosomes revealed by mapping of nuclear lamina interactionsLars Guelen, Ludo Pagie, Emilie Brasset, et al.
Molecular Cancer Therapeutics|September 4, 2008
Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosidesCornelia de Wolf, Robert Jansen, Hiroaki Yamaguchi, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 7, 2012
Lack of ABCG2 shortens latency of BRCA1-deficient mammary tumors and this is not affected by genistein or resveratrolSerge A L Zander, Ariena Kersbergen, Wendy Sol, et al.
Oncogene|April 3, 2020
Integrative analysis of genomic amplification-dependent expression and loss-of-function screen identifies ASAP1 as a driver gene in triple-negative breast cancer progressionJichao He, Ronan P McLaughlin, Lambert van der Beek, et al.
Cancer Research|August 6, 2009
Moderate increase in Mdr1a/1b expression causes in vivo resistance to doxorubicin in a mouse model for hereditary breast cancerMarina Pajic, Jayasree K Iyer, Ariena Kersbergen, et al.
Cancer Research|August 12, 2015
Genome-Wide Identification and Characterization of Novel Factors Conferring Resistance to Topoisomerase II Poisons in CancerRuud H Wijdeven, Baoxu Pang, Sabina Y van der Zanden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2017
Selected Alkylating Agents Can Overcome Drug Tolerance of G0-like Tumor Cells and Eradicate BRCA1-Deficient Mammary Tumors in MiceMarina Pajic, Sohvi Blatter, Charlotte Guyader, et al.
The Journal of Biological Chemistry|July 21, 2004
Factors affecting the level and localization of the transferrin receptor in Trypanosoma bruceiRainer Mussmann, Markus Engstler, Herlinde Gerrits, et al.
Pageof 14